The finding that Oct1 loss resulted in opposing effects in the chemical- vs. Apc/LOH-driven colon cancer models suggested that the two models may differ at a molecular level, such that Oct1’s dominant activity can switch from pro-oncogenic to tumor suppressive. The gene discussed is POU2F1; the disease is neoplasm.